APA

Liou G., El-Remessy A., Ibrahim A., Caldwell R., Khalifa Y., Gunes A. & Nussbaum J. (2009). Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. : Current pharmacogenomics and personalized medicine.

Chicago

Liou Gi, El-Remessy Ab, Ibrahim As, Caldwell Rb, Khalifa Ym, Gunes A and Nussbaum Jj. 2009. Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. : Current pharmacogenomics and personalized medicine.

Harvard

Liou G., El-Remessy A., Ibrahim A., Caldwell R., Khalifa Y., Gunes A. and Nussbaum J. (2009). Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. : Current pharmacogenomics and personalized medicine.

MLA

Liou Gi, El-Remessy Ab, Ibrahim As, Caldwell Rb, Khalifa Ym, Gunes A and Nussbaum Jj. Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. : Current pharmacogenomics and personalized medicine. 2009.